Elevate Medical Group is here to help achieve a healthier you. Our goal is to offer a customized plan that reviews past efforts, considers your unique body composition, and provides a medication treatment regimen that will support your body’s normal biological function to lose weight.
On June 4,2021 the U.S. Food and Drug Administration approved Wegovy (semaglutide) injection (2.4 mg once weekly) for chronic weight management in adults with obesity or overweight with at least one weight-related condition (such as high blood pressure, type 2 diabetes, or high cholesterol), for use in addition to a reduced calorie diet and increased physical activity. This under-the-skin injection is the first approved drug for chronic weight management in adults with general obesity or overweight since 2014. The drug is indicated for chronic weight management in patients with a body mass index (BMI) of 27 kg/m2 or greater who have at least one weight-related ailment or in patients with a BMI of 30 kg/m2 or greater.
Friendly, and supportive treatment environment – Transparent treatment plan with no gimmicks – Our sole focus is helping achieve a healthier you.
Monday – Friday: 8am-6pm
Saturday: By Appointment Only
Sunday: Closed
©2023 Elevate Medical Group. All Right Reserved
